Article
Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.
The international journal of neuropsychopharmacology - 1 Dec 2004
Pae Chi-Un, Yu Hye-Sook, Kim Jung-Jin, Lee Chang-Uk, Lee Soo-Jung, Jun Tae-Youn, Lee Chul, Paik In-Ho
Abstract excerpt
The association between the quinone oxidoreductase gene (NQO1) polymorphism (609C/T) and schizophrenia was examined to replicate and extend the findings of a previous study (Hori et al., 2003). The study sample was 107 schizophrenia in-patients and 106 healthy controls. The distributions of the NQO1 genotypes and alleles were not different between the schizophrenia patients and the controls. However, the...
Topics
- Adult
- Alleles
- Antipsychotic Agents
- Case-Control Studies
- Dyskinesia, Drug-Induced
- Female
- Gene Frequency
- Genotype
- Humans
- Korea
- Male
- Middle Aged
- NAD(P)H Dehydrogenase (Quinone)